IN2013MU01177A - - Google Patents
Info
- Publication number
- IN2013MU01177A IN2013MU01177A IN1177MU2013A IN2013MU01177A IN 2013MU01177 A IN2013MU01177 A IN 2013MU01177A IN 1177MU2013 A IN1177MU2013 A IN 1177MU2013A IN 2013MU01177 A IN2013MU01177 A IN 2013MU01177A
- Authority
- IN
- India
- Prior art keywords
- present
- tadalafil
- stable pharmaceutical
- excipienls
- particle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Abstract
The present invention relates to stable pharmaceutical compositions of Tadalafil for oral administration comprising tadalafil particles having D90 particle si/.e greater than about 40 μm and one or more pharmaceutically acceptable excipienls, Further the present invention also discloses the process for the preparation of the said stable pharmaceutical composition.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2014/000196 WO2014167579A2 (en) | 2013-03-28 | 2014-03-28 | Stable pharmaceutical compositions of tadalafil |
IN1177MU2013 IN2013MU01177A (en) | 2013-03-28 | 2014-03-28 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1177MU2013 IN2013MU01177A (en) | 2013-03-28 | 2014-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01177A true IN2013MU01177A (en) | 2015-04-17 |
Family
ID=51690088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1177MU2013 IN2013MU01177A (en) | 2013-03-28 | 2014-03-28 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2013MU01177A (en) |
WO (1) | WO2014167579A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2016002581A (en) * | 2016-02-26 | 2017-08-25 | Apotex Tech Inc | Novel pharmaceutical formulations comprising a pds5 inhibitor. |
CN113855639B (en) * | 2021-11-04 | 2023-03-24 | 昆明源瑞制药有限公司 | Tadalafil tablet and preparation method thereof |
CN115089551B (en) * | 2022-04-07 | 2024-03-29 | 江西药都仁和制药有限公司 | Tadalafil tablet and preparation method thereof |
WO2023232215A1 (en) * | 2022-06-02 | 2023-12-07 | Rontis Hellas S.A. | Improved pharmaceutical composition containing tadalafil and process for the preparation thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012095151A1 (en) * | 2010-12-23 | 2012-07-19 | Zaklady Farmaceutyczne Polpharma Sa | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof |
EP2654723B1 (en) * | 2010-12-23 | 2014-12-31 | Zaklady Farmaceutyczne Polpharma SA | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof |
WO2013109230A1 (en) * | 2012-01-18 | 2013-07-25 | Mahmut Bilgic | Pharmaceutical compositions comprising tadalafil |
-
2014
- 2014-03-28 WO PCT/IN2014/000196 patent/WO2014167579A2/en active Application Filing
- 2014-03-28 IN IN1177MU2013 patent/IN2013MU01177A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014167579A3 (en) | 2014-12-24 |
WO2014167579A2 (en) | 2014-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201810985XA (en) | Tofacitinib oral sustained release dosage forms | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
MX348823B (en) | Stable formulations of linaclotide. | |
SV2016005236A (en) | COMPOSITE FORMULATION FOR ORAL ADMINISTRATION INCLUDING EZETIMIBE AND ROSUVASTATIN | |
MY193728A (en) | Muscarinic receptor agonists | |
MX2015012414A (en) | Salt of omecamtiv mecarbil and process for preparing salt. | |
IN2013MU03583A (en) | ||
WO2014137797A3 (en) | Stable glucokinase activator compositions | |
WO2015092810A3 (en) | Amorphous form of idelalisib | |
MX2016001422A (en) | Pharmaceutical compositions of fingolimod. | |
IN2013MU01177A (en) | ||
WO2013057741A3 (en) | Pharmaceutical compositions of ursodeoxycholic acid | |
MX366829B (en) | Itraconazole compositions and dosage forms, and methods of using the same. | |
MX364946B (en) | Improved adjuvant system for oral vaccine adminstration. | |
MX2015010486A (en) | Chewable composition for oral administration and process for preparing thereof. | |
GEP201706672B (en) | Dry powder inhaler compositions comprising long acting muscorinic antagonists | |
NZ712341A (en) | A crystalline form of an anxiolytic compound | |
MX2017008983A (en) | Sulfonamide pharmaceutical composition. | |
WO2016197042A8 (en) | Modified or targeted release formulations of linaclotide | |
MX2018011016A (en) | Stable formulations for lyophilizing therapeutic particles. | |
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
MX2019015869A (en) | New oral formulations of belinostat. | |
IN2013CH04314A (en) | ||
MX2018003564A (en) | Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer. | |
IN2013CH05882A (en) |